Synthesis and anti-HIV activity of novel N-1 side chain-modified analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT)

被引:71
作者
Pontikis, R
Benhida, R
Aubertin, AM
Grierson, DS
Monneret, C
机构
[1] INST CURIE, SECT RECH, CNRS, UMR 176, F-75231 PARIS 05, FRANCE
[2] CNRS, INST CHIM SUBST NAT, UPR 2301, F-91198 GIF SUR YVETTE, FRANCE
[3] FAC MED STRASBOURG, INST VIROL, INSERM, U74, F-67000 STRASBOURG, FRANCE
关键词
D O I
10.1021/jm960765a
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 33 N-1 side chain-modified analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)-thymine (1, HEFT) were synthesized and evaluated for their anti-HIV-1 activity. In particular, the influence of substitution of the terminal hydroxy group of the acyclic structure of HEFT and the structural rigidity of this side chain were investigated. Halo (7, 8), azido (9), and amino (10-15) derivatives were synthesized from HEFT via the p-tosylate derivative 6. Acylation of the primary amine 15 afforded the amido analogs 16-20. The diaryl derivatives 26-29 were prepared by reaction of HEFT, or of the 6-(2-pyridylthio) analog 23, with diaryl disulfides in the presence of tri-n-butylphosphine. Compounds 39-41, in which the N-1 side chain is rigidified by incorporation of an E-configured double bond, were obtained by palladium(0)-catalyzed coupling of several different 6-(arylthio)uracil derivatives (37, 38) with allyl acetates 33. Compounds 13, 40a,c,d,f, and 41, incorporating an aromatic ring at the end of the acyclic side chain, were found to be more potent than the known diphenyl-substituted HEFT analog BPT (2), two of them, 40c,d, being 10-fold more active.
引用
收藏
页码:1845 / 1854
页数:10
相关论文
共 47 条
  • [1] BALZARINI J, 1993, MOL PHARMACOL, V44, P694
  • [2] ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS)
    BARRESINOUSSI, F
    CHERMANN, JC
    REY, F
    NUGEYRE, MT
    CHAMARET, S
    GRUEST, J
    DAUGUET, C
    AXLERBLIN, C
    VEZINETBRUN, F
    ROUZIOUX, C
    ROZENBAUM, W
    MONTAGNIER, L
    [J]. SCIENCE, 1983, 220 (4599) : 868 - 871
  • [3] RESISTANCE TO 1-[(2-HYDROXYETHOXY)METHYL]-6-(PHENYLTHIO)THYMINE DERIVATIVES IS GENERATED BY MUTATIONS AT MULTIPLE SITES IN THE HIV-1 REVERSE-TRANSCRIPTASE
    BUCKHEIT, RW
    FLIAKASBOLTZ, V
    YEAGYBARGO, S
    WEISLOW, O
    MAYERS, DL
    BOYER, PL
    HUGHES, SH
    PAN, BC
    CHU, SH
    BADER, JP
    [J]. VIROLOGY, 1995, 210 (01) : 186 - 193
  • [4] CHOU J, 1985, COMPUTER SOFTWARE AP, P19
  • [5] Synthesis and potent anti-HIV-1 activity of novel 6-benzyluracil analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine
    Danel, K
    Larsen, E
    Pedersen, EB
    Vestergaard, BF
    Nielsen, C
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (12) : 2427 - 2431
  • [6] SYNTHESIS AND SOME CNS ACTIVITIES OF NEW BENZOFURANYLACRYLOYLPIPERAZINES
    DAUZONNE, D
    GILLARDIN, JM
    LEPAGE, F
    POINTET, R
    RISSE, S
    LAMOTTE, G
    DEMERSEMAN, P
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1995, 30 (01) : 53 - 59
  • [7] HIV RESISTANCE TO REVERSE-TRANSCRIPTASE INHIBITORS
    DECLERCQ, E
    [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 47 (02) : 155 - 169
  • [8] HIV-1-SPECIFIC RT INHIBITORS - HIGHLY SELECTIVE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 THAT ARE SPECIFICALLY TARGETED AT THE VIRAL REVERSE-TRANSCRIPTASE
    DECLERCQ, E
    [J]. MEDICINAL RESEARCH REVIEWS, 1993, 13 (03) : 229 - 258
  • [9] Consensus symposium on combined antiviral therapy
    deJong, MD
    Boucher, CAB
    Galasso, GJ
    Hirsch, MS
    Kern, ER
    Lange, JMA
    Richman, DD
    [J]. ANTIVIRAL RESEARCH, 1996, 29 (01) : 5 - 29
  • [10] STRUCTURE OF HIV-1 RT/TIBO R-86183 COMPLEX REVEALS SIMILARITY IN THE BINDING OF DIVERSE NONNUCLEOSIDE INHIBITORS
    DING, JP
    DAS, K
    MOEREELS, H
    KOYMANS, L
    ANDRIES, K
    JANSSEN, PAJ
    HUGHES, SH
    ARNOLD, E
    [J]. NATURE STRUCTURAL BIOLOGY, 1995, 2 (05): : 407 - 415